Alfred Health studying MoleMap's AI for skin cancer assessment

Alfred Health's Victorian Melanoma Service is currently conducting a trial into the effectiveness of artificial intelligence for assessments of skin cancer, directly comparing AI results with those of doctors.

The study is designed to be able to prove if the MoleMap algorithm can be used as a diagnostic aid in a specialist setting prior to conducting a much larger trial of the intervention in primary care.

Posted in Australian eHealth

Tags: MoleMap

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2020 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.